VAS
GPCR icon

Vestmark Advisory Solutions’s Structure Therapeutics GPCR Stock Holding History

Vestmark Advisory Solutions’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$404K Hold
7,534
– – ﹤0.01% 1193
2026
Q1 		$363K Hold
7,534
– – ﹤0.01% 1137
2025
Q4 		$524K Buy
+7,534
New +$308K 0.01% 986

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vestmark Advisory Solutions's GPCR Position: Q2 2026 in Review

Vestmark Advisory Solutions held its Structure Therapeutics (GPCR) position steady in Q2 2026 at 7,534 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

Vestmark Advisory Solutions first reported a position in GPCR in Q4 2025 and has held it in 3 quarters since. The position peaked at $524K in Q4 2025. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Vestmark Advisory Solutions held 7,534 shares of Structure Therapeutics worth $404K as of Q2 2026.
  • Vestmark Advisory Solutions left its Structure Therapeutics share count unchanged in Q2 2026.
  • Structure Therapeutics made up ﹤0.01% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #1193 holding.
  • Vestmark Advisory Solutions first reported a position in Structure Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Vestmark Advisory Solutions's Structure Therapeutics position peaked at $524K in Q4 2025.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.